| Structural and molecular interrogation of intact biological systems K Chung, J Wallace, SY Kim, S Kalyanasundaram, AS Andalman, ... Nature 497 (7449), 332-337, 2013 | 2178 | 2013 |
| Natural neural projection dynamics underlying social behavior LA Gunaydin, L Grosenick, JC Finkelstein, IV Kauvar, LE Fenno, ... Cell 157 (7), 1535-1551, 2014 | 1308 | 2014 |
| Recombinase-driver rat lines: tools, techniques, and optogenetic application to dopamine-mediated reinforcement IB Witten, EE Steinberg, SY Lee, TJ Davidson, KA Zalocusky, M Brodsky, ... Neuron 72 (5), 721-733, 2011 | 727 | 2011 |
| Intact-brain analyses reveal distinct information carried by SNc dopamine subcircuits TN Lerner, C Shilyansky, TJ Davidson, KE Evans, KT Beier, KA Zalocusky, ... Cell 162 (3), 635-647, 2015 | 721 | 2015 |
| A Deep Learning Model to Predict a Diagnosis of Alzheimer Disease by Using 18F-FDG PET of the Brain Y Ding, JH Sohn, MG Kawczynski, H Trivedi, R Harnish, NW Jenkins, ... Radiology 290 (2), 456-464, 2019 | 591 | 2019 |
| ImmPort, toward repurposing of open access immunological assay data for translational and clinical research S Bhattacharya, P Dunn, CG Thomas, B Smith, H Schaefer, J Chen, Z Hu, ... Scientific data 5 (1), 1-9, 2018 | 561 | 2018 |
| Prefrontal cortical regulation of brainwide circuit dynamics and reward-related behavior EA Ferenczi, KA Zalocusky, C Liston, L Grosenick, MR Warden, D Amatya, ... Science 351 (6268), aac9698, 2016 | 529 | 2016 |
| Targeting cells with single vectors using multiple-feature Boolean logic LE Fenno, J Mattis, C Ramakrishnan, M Hyun, SY Lee, M He, ... Nature methods 11 (7), 763-772, 2014 | 470 | 2014 |
| Nucleus accumbens D2R cells signal prior outcomes and control risky decision-making KA Zalocusky, C Ramakrishnan, TN Lerner, TJ Davidson, B Knutson, ... Nature 531 (7596), 642-646, 2016 | 224 | 2016 |
| Neuronal ApoE upregulates MHC-I expression to drive selective neurodegeneration in Alzheimer’s disease KA Zalocusky, R Najm, AL Taubes, Y Hao, SY Yoon, N Koutsodendris, ... Nature neuroscience 24 (6), 786-798, 2021 | 104 | 2021 |
| Experimental and real-world evidence supporting the computational repurposing of bumetanide for APOE4-related Alzheimer’s disease A Taubes, P Nova, KA Zalocusky, I Kosti, M Bicak, MY Zilberter, Y Hao, ... Nature Aging 1 (10), 932-947, 2021 | 70 | 2021 |
| The 10,000 immunomes project: building a resource for human immunology KA Zalocusky, MJ Kan, Z Hu, P Dunn, E Thomson, J Wiser, ... Cell reports 25 (2), 513-522. e3, 2018 | 45 | 2018 |
| Optogenetics in the behaving rat: integration of diverse new technologies in a vital animal model K Zalocusky, K Deisseroth Optogenetics 1, 1-17, 2013 | 43 | 2013 |
| In vivo chimeric Alzheimer’s disease modeling of apolipoprotein E4 toxicity in human neurons R Najm, KA Zalocusky, M Zilberter, SY Yoon, Y Hao, N Koutsodendris, ... Cell reports 32 (4), 2020 | 32 | 2020 |
| Sex-specific cross tissue meta-analysis identifies immune dysregulation in women with Alzheimer’s disease MD Paranjpe, S Belonwu, JK Wang, T Oskotsky, A Gupta, A Taubes, ... Frontiers in Aging Neuroscience 13, 735611, 2021 | 26 | 2021 |
| Descriptive epidemiology of 16,780 hospitalized COVID-19 patients in the United States D Chawla, S Rizzo, K Zalocusky, D Keebler, J Chia, L Lindsay, V Yau, ... MedRxiv, 2020.07. 17.20156265, 2020 | 24 | 2020 |
| Severity of COVID-19 and adverse long-term outcomes: a retrospective cohort study based on a US electronic health record database N Jovanoski, X Chen, U Becker, K Zalocusky, D Chawla, L Tsai, M Borm, ... BMJ open 11 (12), e056284, 2021 | 23 | 2021 |
| An Alzheimer’s-disease-protective APOE mutation KA Zalocusky, MR Nelson, Y Huang Nature Medicine 25 (11), 1648-1649, 2019 | 20 | 2019 |
| Current challenges in optogenetics KA Zalocusky, LE Fenno, K Deisseroth Optogenetics, 23-33, 2013 | 13 | 2013 |
| INTRSECT: single-component targeting of cells using multiple-feature Boolean logic LE Fenno, J Mattis, C Ramakrishnan, M Hyun, SY Lee, M He, ... Nature methods 11 (7), 763, 2014 | 9 | 2014 |
Karl DeisserothBioengineering and Psychiatry, Stanford UniversityVerified email at stanford.edu
